Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL

P Bader,Jeremy Hancock,Hermann Kreyenberg,N Goulden,D. Niethammer,A. Oakhill,Colin G. Steward,Rupert Handgretinger,James F. Beck,T Klingebiel

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL

2002

P Bader
Jeremy Hancock
Hermann Kreyenberg
N Goulden
D. Niethammer
A. Oakhill
Colin G. Steward
Rupert Handgretinger
James F. Beck
T Klingebiel

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL

Keywords:

Cancer research
Acute lymphocytic leukemia
Minimal residual disease
Oncology
Bone marrow
Stem cell
Transplantation
Immunology
Internal medicine
Medicine
post transplant

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

165

Citations